Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Plasma and cell separator

FY 2012-13

Summary
Cell separation platforms enable cells to be isolated and analyzed for diagnosis and prognosis of particular diseases, for example, the isolation of circulating tumor cells (CTCs) facilitates detection of cancer. Many methods exist for separating cells, including traditional membrane filtration- or density medium-based laboratory methods. More recently, microfluidic techniques have enabled smaller sample volumes, faster processing times, and less expensive procedures to be employed. CTCs are present in blood at extremely low frequencies, so methods to concentrate the cells are required to enable their detection and reduce the volume of blood that must be processed. The application of microfluidics technologies that can concentrate CTCs by exploiting differences between these and other cell types could greatly improve current methods for detection of CTCs. A first time collaboration will be established between Dr. Grecov from the University of British Columbia and STEMCELL Technologies to develop a technique to facilitate the cell separation step that remains a prerequisite for diagnosis and prognosis of many diseases. The goal is to achieve effective and efficient isolation of cells from small sample sizes in a short period of time, using a device compatible with lab and point-of-care diagnostic devices. This proposal targets the diagnosis and prognosis of cancer both within Canada and globally, through the determination of Circulating Tumor Cells (CTC) counts, using blood samples. The proposed method will give physicians access to consistent standardized results, in a short period of time, thereby allowing faster and more accurate early-stage diagnoses. This in turn will reduce the cost of unnecessary hospitalization, and the added costs related to late diagnosis.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
435582-2012
Name nom
Grecov, Dana
Department département
Mechanical Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2200
Research subject group en
Fluid mechanics
Research subject group fr
Mécanique des fluides
Research subject en
Fluid mechanics
Research subject fr
Mécanique des fluides
Partie
1
Nb partie
1
Application title
Plasma and cell separator
Keyword
NSERC
Application summary
Cell separation platforms enable cells to be isolated and analyzed for diagnosis and prognosis of particular diseases, for example, the isolation of circulating tumor cells (CTCs) facilitates detection of cancer. Many methods exist for separating cells, including traditional membrane filtration- or density medium-based laboratory methods. More recently, microfluidic techniques have enabled smaller sample volumes, faster processing times, and less expensive procedures to be employed. CTCs are present in blood at extremely low frequencies, so methods to concentrate the cells are required to enable their detection and reduce the volume of blood that must be processed. The application of microfluidics technologies that can concentrate CTCs by exploiting differences between these and other cell types could greatly improve current methods for detection of CTCs. A first time collaboration will be established between Dr. Grecov from the University of British Columbia and STEMCELL Technologies to develop a technique to facilitate the cell separation step that remains a prerequisite for diagnosis and prognosis of many diseases. The goal is to achieve effective and efficient isolation of cells from small sample sizes in a short period of time, using a device compatible with lab and point-of-care diagnostic devices. This proposal targets the diagnosis and prognosis of cancer both within Canada and globally, through the determination of Circulating Tumor Cells (CTC) counts, using blood samples. The proposed method will give physicians access to consistent standardized results, in a short period of time, thereby allowing faster and more accurate early-stage diagnoses. This in turn will reduce the cost of unnecessary hospitalization, and the added costs related to late diagnosis.